NL-OMON38519
Completed
Not Applicable
Blood-Brain Barrier permeability quantification in cerebral small vessel disease -- reproducibility of dynamic contrast-enhanced MRI - Blood-brain barrier quantification in cerebral small vessel disease
Medisch Universitair Ziekenhuis Maastricht0 sites20 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cerebral small vessel disease
- Sponsor
- Medisch Universitair Ziekenhuis Maastricht
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All subjects:
- •\- Age \>18 years old
- •\- The condition of the patient must be well enough to allow participation in the study, which is decided in consultation with the treating physician.;cSVD patients:
- •\- patients who present with a transient ischemic attack (TIA) and cSVD related abnormalities on brain MRI. TIA patients are defined as patients with stroke like symptoms that last no longer than 24 hours. MRI abnormalities include extended white matter lesions, (asymptomatic) lacunar infarcts, microbleeds and enlarged Virchow\-Robin spaces. The patients are eligible when the first DCE\-MRI scan can be performed 8\-12 weeks after the TIA to avoid the acute phase, and the second MRI\-scan within four weeks after the first.;Cortical stroke or primary intracerebral hemorrhage patients:
- •\- patients who have a clear clinical presentation of either cortical stroke or primary intracerebral hemorrhage confirmed on brain CT. The patients are eligible when the DCE\-MRI scans can be performed within 0\-6 weeks of the vascular event and on two subsequent days as the vascular permeability may change significantly on the timescale of weeks.
Exclusion Criteria
- •All subjects:
- •\- History of cerebrovascular disease (e.g. ischemic/hemorrhagic stroke)
- •\- History of other diseases of the central nervous system (e.g. epilepsy, brain tumor, multiple sclerosis)
- •\- Contra\-indications for MRI examination: e.g. pacemaker; neurostimulator; medication pump; cochlear or hearing implant; tattoos or other items that cannot be removed and include metal parts (for instance from operations in the past); metal splinter in the eye; pregnancy and claustrophobia; brain vessel clamps; denture, which contains magnets.
- •\- Contra\-indication for MRI contrast agent: e.g. strong suspicion for impaired kidney function, previous allergic reaction to contrast agent, dialysis patients
- •\- Psychiatric co\-morbidity and inability to perform the (DCE\-)MRI scans.;cSVD patients
- •\- Patients with a potential cardioembolic source (e.g. atrial fibrillation)
- •\- Stenosis of \*50% of one or both internal carotid arteries ;Cortical stroke or primary intracerebral hemorrhage patients:
- •\- Extensive cSVD related abnormalities on brain MRI
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Quantitative blood-brain barrier permeability and susceptibility mapping for patients with CADASIL and suspected to have CADASICADASIJPRN-UMIN000035081agoya City University40
Active, not recruiting
Not Applicable
Studies on Permeability of the Blood-Brain-Barrier for Escitaloprame related to various Genotypes of the ABCB1-Gene: Effects on Sleep and Motoric Learning - Escitaloprame, sleep, blood-brain-barrierEffects on sleep electroencephalogram and motoric learning in healthy volunteers related to the permeability of the blood-brain-barrier related to genotypes of the ABCB 1 geneEUCTR2006-001491-21-DEMax Planck Institute of Psychiatry58
Recruiting
Not Applicable
Measuring blood-brain barrier integrity non-invasively with MRINL-OMON53975Amsterdam UMC
Recruiting
Not Applicable
Blood-brain barrier permeability and cerebral perfusion in Alzheimer*s diseaseneurodegeneratieve aandoeningenAlzheimer's diseasedementiaNL-OMON38302niversiteit Maastricht60
Recruiting
Not Applicable
Blood brain barrier permeability and inflammatory biomarkers in patients with depressioF32.2F32.3F33.2F33.3Severe depressive episode without psychotic symptomsSevere depressive episode with psychotic symptomsRecurrent depressive disorder, current episode severe without psychotic symptomsRecurrent depressive disorder, current episode severe with psychotic symptomsDRKS00022091Klinik für Psychiatrie, Psychosomatik und PsychotherapieUniversitätsklinikum Frankfurt100